<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>oc000199</Identifier>
    <IdentifierDoi>10.3205/oc000199</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-oc0001997</IdentifierUrn>
    <ArticleType>Case Report</ArticleType>
    <TitleGroup>
      <Title language="en">Simultaneous bilateral inflammatory choroidal neovascularization in a case of healed serpiginous-like choroiditis</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Sood</Lastname>
          <LastnameHeading>Sood</LastnameHeading>
          <Firstname>Gitanjli</Firstname>
          <Initials>G</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Samanta</Lastname>
          <LastnameHeading>Samanta</LastnameHeading>
          <Firstname>Ramanuj</Firstname>
          <Initials>R</Initials>
        </PersonNames>
        <Address>Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Virbhadra Road Shivaji Nagar, Rishikesh, 249203 Uttarakhand, India, Phone: &#43;91 8872292345<Affiliation>Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India</Affiliation></Address>
        <Email>ramanuj.samanta&#64;gmail.com</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Kumawat</Lastname>
          <LastnameHeading>Kumawat</LastnameHeading>
          <Firstname>Devesh</Firstname>
          <Initials>D</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Ophthalmology, Lady Hardinge Medical College, New Delhi, India</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Nishant</Lastname>
          <LastnameHeading>Nishant</LastnameHeading>
          <Firstname>Prateek</Firstname>
          <Initials>P</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">inflammatory choroidal neovascularization</Keyword>
      <Keyword language="en">serpiginous-like choroiditis</Keyword>
      <Keyword language="en">anti-VEGF</Keyword>
      <Keyword language="en">posterior uveitis</Keyword>
      <Keyword language="en">TB choroiditis</Keyword>
    </SubjectGroup>
    <DatePublishedList>
      
    <DatePublished>20220520</DatePublished></DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>2193-1496</ISSN>
        <Volume>12</Volume>
        <JournalTitle>GMS Ophthalmology Cases</JournalTitle>
        <JournalTitleAbbr>GMS Ophthalmol Cases</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>12</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="en" linked="yes"><Pgraph><Mark1>Objective:</Mark1> Inflammatory choroidal neovascularization (i-CNV) is an infrequent but sight-threatening complication of posterior uveitis. Although it can occur in a wide range of infectious and non-infectious uveitides, presence of simultaneous bilateral i-CNV is rare. In this report, we present a unique case of bilateral simultaneous i-CNV in a young patient of healed tubercular serpiginous-like choroiditis.</Pgraph><Pgraph><Mark1>Method:</Mark1> A 20-year-old male presented with recent worsening of vision in the right eye for one month. Fundus examination revealed bilateral multifocal healed choroiditis lesions with right eye tiny subfoveal hemorrhage raising the suspicion of an underlying choroidal neovascularization. Fundus fluorescein angiography and optical coherence tomography confirmed presence of choroidal neovascular membrane in both eyes.</Pgraph><Pgraph><Mark1>Result:</Mark1> Resolution of activity was noted in both eyes after bilateral sequential intravitreal bevacizumab injections.</Pgraph><Pgraph><Mark1>Conclusion:</Mark1> Inflammatory choroidal neovascularization may be seen in patients with healed tubercular serpiginous-like choroiditis, after a long period of quiescence. Simultaneous bilateral presentation is rare but possible, requiring mandatory multimodal imaging of both eyes under high index of suspicion. Early institution of anti-vascular endothelial growth factor may salvage optimum vision in such a scenario.</Pgraph></Abstract>
    <TextBlock linked="yes" name="Introduction">
      <MainHeadline>Introduction</MainHeadline><Pgraph>Inflammatory choroidal neovascularization (i-CNV) is an uncommon complication of posterior uveitis, rarer with bilateral disease <TextLink reference="1"></TextLink>. Diagnosis is often difficult in presence of pre-existing scarring, simultaneous choroiditis lesions, cataract and vitreous haze <TextLink reference="2"></TextLink>. Ancillary investigations like optical coherence tomography (OCT) and fundus fluorescein angiography (FFA) may help in diagnosis of the clinically doubtful cases <TextLink reference="3"></TextLink>. It can lead to permanent drop in vision if missed and not treated on time <TextLink reference="4"></TextLink>. This case highlights the diagnosis of i-CNV in one eye based on patient&#8217;s symptom and clinical cue; i-CNV in the fellow eye was confirmed on FFA in the pretext of equivocal fundus findings.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Case description">
      <MainHeadline>Case description</MainHeadline><Pgraph>A 20-year-old Asian-Indian male presented with bilateral painless diminution of vision for five years with recent worsening in the right eye (OD) for last one month. Ocular examination revealed best-corrected visual acuity (BCVA) of 20&#47;200 in OD and 20&#47;120 in the left eye (OS). Intraocular pressures and anterior segments were unremarkable. Dilated fundus showed (Figure 1A&#8211;B <ImgLink imgNo="1" imgType="figure"/>) bilateral multiple well-defined choroiditis lesions with overlying pigment clumping at the posterior pole and mid-periphery. There was no associated vitritis. Careful examination also revealed a small subretinal hemorrhage close to the fovea in OD (inset; Figure 1A <ImgLink imgNo="1" imgType="figure"/>) and a doubtful yellowish subretinal lesion adjacent to the central pigmented healed choroiditis scar in OS (inset; Figure 1B <ImgLink imgNo="1" imgType="figure"/>). Fundus autofluorescence (FAF) of both eyes (Figure 1C&#8211;D <ImgLink imgNo="1" imgType="figure"/>) showed uniform hypoautofluorescence over choroiditis patches suggestive of healed lesions. FFA (Figure 2A&#8211;D <ImgLink imgNo="2" imgType="figure"/>) and OCT (Figure 2E&#8211;F <ImgLink imgNo="2" imgType="figure"/>) was suggestive of bilateral i-CNV.</Pgraph><Pgraph></Pgraph><Pgraph>Review of records revealed an induration of 15&#215;10 mm on tuberculin skin test, non-reactive VDRL, normal chest imaging and unremarkable laboratory reports. Past medical history revealed a diagnosis of tubercular meningitis with associated hydrocephalus at 10-years of age. The patient received antitubercular therapy (ATT) for nine months during that episode and also underwent ventriculoperitoneal shunt surgery.</Pgraph><Pgraph>Based on the clinical findings and ancillary investigations, a diagnosis of bilateral i-CNV associated with healed tubercular serpiginous-like choroiditis (SLC) was made. The patient underwent bilateral intravitreal bevacizumab (IVB; 1.25mg&#47;0.05ml) injection at two weeks interval (OD treated first). After a month, OD injection was repeated due to persistent i-CNV.</Pgraph><Pgraph>The patient was followed up monthly thereafter and at six-months follow-up, his BCVA remained stable at 20&#47;120 in both eyes. Fundus showed resolution of i-CNV (Figure 3A&#8211;B <ImgLink imgNo="3" imgType="figure"/>) and OCT showed bilateral subfoveal organized membrane without any associated intra-retinal&#47;sub-retinal fluid (Figure 3C&#8211;D <ImgLink imgNo="3" imgType="figure"/>). The patient was advised monthly follow-up to look for any recurrence.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Discussion">
      <MainHeadline>Discussion</MainHeadline><Pgraph>I-CNV is an uncommon but potentially sight-threatening complication, mostly associated with posterior uveitis or panuveitis (2&#8211;2.7&#37;), less commonly with anterior uveitis and rarely with intermediate uveitis <TextLink reference="1"></TextLink>. Eyes with i-CNV in one eye have a seven-fold increased risk of developing it in the fellow eye. Various infectious (histoplasmosis, toxoplasmosis, toxocariasis, tuberculosis) and non-infectious (Vogt-Koyanagi-Harada&#8217;s disease, punctate inner choroidopathy, multifocal choroiditis, serpiginous choroiditis) uveitis have been reported to be associated with i-CNV <TextLink reference="1"></TextLink>, <TextLink reference="3"></TextLink>. However, exact prevalence of i-CNV following intraocular tuberculosis is unknown as it is uncommon <TextLink reference="3"></TextLink>. In a  retrospective study from the Indian subcontinent involving 49 eyes with i-CNV, tubercular etiology was noted in 14 eyes. Among these, only two eyes had SLC <TextLink reference="5"></TextLink>.</Pgraph><Pgraph>While extrafoveal i-CNV is mostly asymptomatic and incidentally detected on imaging, lesions close to the fovea may present with diminution of vision or new onset metamorphopsia. Diagnosis of such lesions are challenging and are often missed due to various factors like significant background scarring, intense pigmentation, poorly dilating pupil, cataract, vitreous haze and sunset glow of fundus <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. A small peripapillary lesion or tiny subretinal hemorrhage are frequently overlooked until more obvious fundus changes occur or the patient presents with symptoms. In our case also, the patient was seen at multiple clinics elsewhere before presenting to us and was advised conservative management in view of healed lesions. A small subretinal hemorrhage in OD and a suspicious yellowish lesion in OS prompted us to investigate thoroughly. Although OD had a visible diagnostic clue, diagnosis in OS could have been missed unless the patient was subjected to FFA and OCT.</Pgraph><Pgraph>The lesions of i-CNV need to be differentiated from active choroiditis patches because treatment differs. Both can present clinically as yellowish lesions at the posterior pole with ill-defined margins with or without overlying fluid. On OCT, i-CNV presents mostly as type 2 lesion; another distinctive feature is the &#8216;pitchfork sign&#8217; in which there are hyperreflective projections from the membrane to the overlying retina <TextLink reference="6"></TextLink>. Active choroiditis lesions may show disruption in the outer retina with edema in OCT, but there is deeper penetration of OCT signal beneath the lesion, which is absent in CNVM <TextLink reference="7"></TextLink>.</Pgraph><Pgraph>The majority of i-CNV present as classic lesion in FFA; focal breach in retinal pigment epithelium (RPE) due to infection and inflammation is responsible for growth and progression of the neovascular membrane in the outer retinal space <TextLink reference="3"></TextLink>, <TextLink reference="8"></TextLink>. In the early phase of FFA, the CNVM is iso- or hyperfluorescent, while active lesions are hypo- or isofluorescent. Late leakage is present in both, and presence of extensive scarring can make interpretation difficult. FFA may be more sensitive in detecting CNVM in patients with multifocal choroiditis than OCT <TextLink reference="8"></TextLink>, especially in those without substantial fluid or cystic spaces on OCT. Thus, even in absence of fluid on OCT, suspicious cases should undergo FFA to rule out active CNVM, as shown in our case also. Indocyanine green angiography (ICG) can also provide additional information regarding the primary choroidal pathology, which might have contributed to the formation of i-CNV.</Pgraph><Pgraph>OCT-angiography (OCTA) may be the only investigative modality that helps us differentiate between active choroiditis and i-CNV with certainity, especially in equivocal cases. OCTA helps in identifying the vascular network even in cases with inconclusive FFA <TextLink reference="9"></TextLink>, <TextLink reference="10"></TextLink>. There will be no abnormal blood flow signals over an inflammatory lesion <TextLink reference="11"></TextLink>. Up to 14&#37; additional lesions were picked up on OCTA that were missed on conventional FFA and OCT <TextLink reference="10"></TextLink>, <TextLink reference="12"></TextLink>. Although OCTA could not be performed in this case, i-CNV was confirmed using other imaging modalities.</Pgraph><Pgraph>Inflammation and angiogenesis both need to be managed in a case of i-CNV <TextLink reference="13"></TextLink>. As compared to age-related macular degeneration (ARMD), these patients require fewer anti-VEGF injections (average 2.7) with lesser recurrences due to well-defined focal nature of the membrane <TextLink reference="3"></TextLink>, <TextLink reference="9"></TextLink>. Associated active inflammation may need treatment with steroids and&#47;or immunosuppressive medications to get the best outcome and reduce recurrences. Laser photocoagulation and photodynamic therapy were also used in the past, but anti-VEGF agents are the accepted primary treatment of i-CNV in the current era <TextLink reference="14"></TextLink>. Roy et al., in their study including thirty eyes of i-CNV of varied etiology, have demonstrated improvement of visual acuity in 53.3&#37; and stabilization in 26.6&#37; eyes, with mean 2.76 anti-VEGF injections in a mean follow-up duration of 17.93&#177;14.28 months <TextLink reference="13"></TextLink>. In another study by Lott et al. including 34 i-CNV eyes, improvement of visual acuity was noted in 17&#37; and stabilization in 33&#37; at six months follow-up with a mean of two IVB injections <TextLink reference="15"></TextLink>. Kim et al. have reported four cases of CNVM associated with presumed tubercular chorioretinitis and demonstrated favourable outcome with ATT, oral corticosteroids, and intravitreal anti-VEGF agents <TextLink reference="16"></TextLink>.</Pgraph><Pgraph>Occurrence of i-CNV following tubercular SLC is infrequently reported in literature despite tuberculosis being one of the leading causes of infectious uveitis in endemic regions like the Indian subcontinent. Invernizzi et al. have described five cases of i-CNV as a rare and unusual presenting sign of intraocular tuberculosis from a non-endemic country, which were initially misdiagnosed as exudative ARMD <TextLink reference="17"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Conclusion">
      <MainHeadline>Conclusion</MainHeadline><Pgraph>This report is unique in depicting simultaneous bilateral presentation of i-CNV following healed tubercular SLC and emphasizes the importance of detailed examination of the fellow eye with appropriate ancillary imaging under high index of suspicion. Early treatment with anti-VEGF can be promising, although they may require long-term follow-up to look for any recurrences.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Notes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Baxter SL</RefAuthor>
        <RefAuthor>Pistilli M</RefAuthor>
        <RefAuthor>Pujari SS</RefAuthor>
        <RefAuthor>Liesegang TL</RefAuthor>
        <RefAuthor>Suhler EB</RefAuthor>
        <RefAuthor>Thorne JE</RefAuthor>
        <RefAuthor>Foster CS</RefAuthor>
        <RefAuthor>Jabs DA</RefAuthor>
        <RefAuthor>Levy-Clarke GA</RefAuthor>
        <RefAuthor>Nussenblatt RB</RefAuthor>
        <RefAuthor>Rosenbaum JT</RefAuthor>
        <RefAuthor>Kempen JH</RefAuthor>
        <RefTitle>Risk of choroidal neovascularization among the uveitides</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>468-77</RefPage>
        <RefTotal>Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep;156(3):468-77.e2. DOI: 10.1016&#47;j.ajo.2013.04.040</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2013.04.040</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>D&#8217;Ambrosio E</RefAuthor>
        <RefAuthor>Tortorella P</RefAuthor>
        <RefAuthor>Iannetti L</RefAuthor>
        <RefTitle>Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>450428</RefPage>
        <RefTotal>D&#8217;Ambrosio E, Tortorella P, Iannetti L. Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy. J Ophthalmol. 2014;2014:450428. DOI: 10.1155&#47;2014&#47;450428</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2014&#47;450428</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Agarwal A</RefAuthor>
        <RefAuthor>Invernizzi A</RefAuthor>
        <RefAuthor>Singh RB</RefAuthor>
        <RefAuthor>Foulsham W</RefAuthor>
        <RefAuthor>Aggarwal K</RefAuthor>
        <RefAuthor>Handa S</RefAuthor>
        <RefAuthor>Agrawal R</RefAuthor>
        <RefAuthor>Pavesio C</RefAuthor>
        <RefAuthor>Gupta V</RefAuthor>
        <RefTitle>An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Ophthalmic Inflamm Infect</RefJournal>
        <RefPage>13</RefPage>
        <RefTotal>Agarwal A, Invernizzi A, Singh RB, Foulsham W, Aggarwal K, Handa S, Agrawal R, Pavesio C, Gupta V. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. 2018 Sep;8(1):13. DOI: 10.1186&#47;s12348-018-0155-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12348-018-0155-6</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Miller DG</RefAuthor>
        <RefAuthor>Singerman LJ</RefAuthor>
        <RefTitle>Vision loss in younger patients: a review of choroidal neovascularization</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Optom Vis Sci</RefJournal>
        <RefPage>316-25</RefPage>
        <RefTotal>Miller DG, Singerman LJ. Vision loss in younger patients: a review of choroidal neovascularization. Optom Vis Sci. 2006 May;83(5):316-25. DOI: 10.1097&#47;01.opx.0000216019.88256.eb</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;01.opx.0000216019.88256.eb</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Ganesh S</RefAuthor>
        <RefAuthor>Ahmed A</RefAuthor>
        <RefAuthor>Biswas J</RefAuthor>
        <RefTitle>Analysis of the Clinical Profile and Management of Inflammatory Choriodal Neovascular Membranes in Uveitic Eyes: A Study from a Tertiary Referral Center</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Ocul Immunol Inflamm</RefJournal>
        <RefPage>424-34</RefPage>
        <RefTotal>Ganesh S, Ahmed A, Biswas J. Analysis of the Clinical Profile and Management of Inflammatory Choriodal Neovascular Membranes in Uveitic Eyes: A Study from a Tertiary Referral Center. Ocul Immunol Inflamm. 2019;27(3):424-34. DOI: 10.1080&#47;09273948.2017.1375119</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1080&#47;09273948.2017.1375119</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Hoang QV</RefAuthor>
        <RefAuthor>Cunningham ET Jr</RefAuthor>
        <RefAuthor>Sorenson JA</RefAuthor>
        <RefAuthor>Freund KB</RefAuthor>
        <RefTitle>The &#8220;pitchfork sign&#8221; a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1049-55</RefPage>
        <RefTotal>Hoang QV, Cunningham ET Jr, Sorenson JA, Freund KB. The &#8220;pitchfork sign&#8221; a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina. 2013 May;33(5):1049-55. DOI: 10.1097&#47;IAE.0b013e31827e25b8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0b013e31827e25b8</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Amer R</RefAuthor>
        <RefAuthor>Priel E</RefAuthor>
        <RefAuthor>Kramer M</RefAuthor>
        <RefTitle>Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>949-57</RefPage>
        <RefTotal>Amer R, Priel E, Kramer M. Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):949-57. DOI: 10.1007&#47;s00417-015-2930-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-015-2930-5</RefLink>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Kotsolis AI</RefAuthor>
        <RefAuthor>Killian FA</RefAuthor>
        <RefAuthor>Ladas ID</RefAuthor>
        <RefAuthor>Yannuzzi LA</RefAuthor>
        <RefTitle>Fluorescein angiography and optical coherence tomography concordance for choroidal neovascularisation in multifocal choroidtis</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1506-8</RefPage>
        <RefTotal>Kotsolis AI, Killian FA, Ladas ID, Yannuzzi LA. Fluorescein angiography and optical coherence tomography concordance for choroidal neovascularisation in multifocal choroidtis. Br J Ophthalmol. 2010 Nov;94(11):1506-8. DOI: 10.1136&#47;bjo.2009.159913</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.2009.159913</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Eter N</RefAuthor>
        <RefAuthor>Spaide RF</RefAuthor>
        <RefTitle>Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>691-6</RefPage>
        <RefTotal>Eter N, Spaide RF. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina. 2005 Sep;25(6):691-6. DOI: 10.1097&#47;00006982-200509000-00002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200509000-00002</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Bansal R</RefAuthor>
        <RefAuthor>Bansal P</RefAuthor>
        <RefAuthor>Gupta A</RefAuthor>
        <RefAuthor>Gupta V</RefAuthor>
        <RefAuthor>Dogra MR</RefAuthor>
        <RefAuthor>Singh R</RefAuthor>
        <RefAuthor>Katoch D</RefAuthor>
        <RefTitle>Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Ocul Immunol Inflamm</RefJournal>
        <RefPage>554-62</RefPage>
        <RefTotal>Bansal R, Bansal P, Gupta A, Gupta V, Dogra MR, Singh R, Katoch D. Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes. Ocul Immunol Inflamm. 2017;25(4):554-62. DOI: 10.3109&#47;09273948.2016.1160128</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3109&#47;09273948.2016.1160128</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Cheng L</RefAuthor>
        <RefAuthor>Chen X</RefAuthor>
        <RefAuthor>Weng S</RefAuthor>
        <RefAuthor>Mao L</RefAuthor>
        <RefAuthor>Gong Y</RefAuthor>
        <RefAuthor>Yu S</RefAuthor>
        <RefAuthor>Xu X</RefAuthor>
        <RefTitle>Spectral-Domain Optical Coherence Tomography Angiography Findings in Multifocal Choroiditis With Active Lesions</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>145-61</RefPage>
        <RefTotal>Cheng L, Chen X, Weng S, Mao L, Gong Y, Yu S, Xu X. Spectral-Domain Optical Coherence Tomography Angiography Findings in Multifocal Choroiditis With Active Lesions. Am J Ophthalmol. 2016 Sep;169:145-61. DOI: 10.1016&#47;j.ajo.2016.06.029</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2016.06.029</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Astroz P</RefAuthor>
        <RefAuthor>Miere A</RefAuthor>
        <RefAuthor>Mrejen S</RefAuthor>
        <RefAuthor>Sekfali R</RefAuthor>
        <RefAuthor>Souied EH</RefAuthor>
        <RefAuthor>Jung C</RefAuthor>
        <RefAuthor>Nghiem-Buffet S</RefAuthor>
        <RefAuthor>Cohen SY</RefAuthor>
        <RefTitle>Optical coherence tomography angiography to distinguish choroidal neovascularization from macular inflammatory lesions in multifocal choroiditis</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>299-309</RefPage>
        <RefTotal>Astroz P, Miere A, Mrejen S, Sekfali R, Souied EH, Jung C, Nghiem-Buffet S, Cohen SY. Optical coherence tomography angiography to distinguish choroidal neovascularization from macular inflammatory lesions in multifocal choroiditis. Retina. 2018 Feb;38(2):299-309. DOI: 10.1097&#47;IAE.0000000000001617</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000001617</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Roy R</RefAuthor>
        <RefAuthor>Saurabh K</RefAuthor>
        <RefAuthor>Bansal A</RefAuthor>
        <RefAuthor>Kumar A</RefAuthor>
        <RefAuthor>Majumdar AK</RefAuthor>
        <RefAuthor>Paul SS</RefAuthor>
        <RefTitle>Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Indian J Ophthalmol</RefJournal>
        <RefPage>295-300</RefPage>
        <RefTotal>Roy R, Saurabh K, Bansal A, Kumar A, Majumdar AK, Paul SS. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor. Indian J Ophthalmol. 2017 Apr;65(4):295-300. DOI: 10.4103&#47;ijo.IJO&#95;262&#95;16</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;ijo.IJO&#95;262&#95;16</RefLink>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Neri P</RefAuthor>
        <RefAuthor>Lettieri M</RefAuthor>
        <RefAuthor>Fortuna C</RefAuthor>
        <RefAuthor>Manoni M</RefAuthor>
        <RefAuthor>Giovannini A</RefAuthor>
        <RefTitle>Inflammatory choroidal neovascularization</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Middle East Afr J Ophthalmol</RefJournal>
        <RefPage>245-51</RefPage>
        <RefTotal>Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. 2009 Oct;16(4):245-51. DOI: 10.4103&#47;0974-9233.58422</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;0974-9233.58422</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Lott MN</RefAuthor>
        <RefAuthor>Schiffman JC</RefAuthor>
        <RefAuthor>Davis JL</RefAuthor>
        <RefTitle>Bevacizumab in inflammatory eye disease</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>711-7</RefPage>
        <RefTotal>Lott MN, Schiffman JC, Davis JL. Bevacizumab in inflammatory eye disease. Am J Ophthalmol. 2009 Nov;148(5):711-7.e2. DOI: 10.1016&#47;j.ajo.2009.06.010</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2009.06.010</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Lee Kim E</RefAuthor>
        <RefAuthor>Rodger DC</RefAuthor>
        <RefAuthor>Rao NA</RefAuthor>
        <RefTitle>Choroidal neovascularization secondary to tuberculosis: Presentation and management</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Am J Ophthalmol Case Rep</RefJournal>
        <RefPage>124-9</RefPage>
        <RefTotal>Lee Kim E, Rodger DC, Rao NA. Choroidal neovascularization secondary to tuberculosis: Presentation and management. Am J Ophthalmol Case Rep. 2017 Jan;5:124-9. DOI: 10.1016&#47;j.ajoc.2016.12.025</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajoc.2016.12.025</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Invernizzi A</RefAuthor>
        <RefAuthor>Agarwal A</RefAuthor>
        <RefAuthor>Di Nicola M</RefAuthor>
        <RefAuthor>Franzetti F</RefAuthor>
        <RefAuthor>Staurenghi G</RefAuthor>
        <RefAuthor>Viola F</RefAuthor>
        <RefTitle>Choroidal neovascular membranes secondary to intraocular tuberculosis misdiagnosed as neovascular age-related macular degeneration</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Eur J Ophthalmol</RefJournal>
        <RefPage>216-24</RefPage>
        <RefTotal>Invernizzi A, Agarwal A, Di Nicola M, Franzetti F, Staurenghi G, Viola F. Choroidal neovascular membranes secondary to intraocular tuberculosis misdiagnosed as neovascular age-related macular degeneration. Eur J Ophthalmol. 2018 Mar;28(2):216-24. DOI: 10.5301&#47;ejo.5001047</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.5301&#47;ejo.5001047</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <Figure format="png" height="695" width="693">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Figure 1: Fundus photo of the right eye (A) and the left eye (B) at presentation showing multiple pigmented healed choroiditis patches of variable size at the posterior pole. A small retinal haemorrhage adjacent to yellowish membranous lesion (inset; A) and a suspicious yellowish membranous lesion (inset; B) was also noted. Fundus autofluorescence of the right eye (C) and the left eye (D) at presentation showing uniform hypoautofluorescence over the choroiditis lesions suggestive of healed lesions.</Mark1></Pgraph></Caption>
        </Figure>
        <Figure format="png" height="906" width="670">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption><Pgraph><Mark1>Figure 2: FFA of the right eye in arterio-venous phase (A) showing hypofluorescent patches with hyperfluorescent borders and an area of blocked fluorescence at the fovea with surrounding punctate fluorescence (white arrow) that increases and leaks in late phase (B) suggestive of CNVM. FFA of the left eye (C&#8211;D) also reveals a juxta-foveal area of hyperfluorescence (white arrow) compatible with CNVM. OCT line scan through the fovea at presentation shows a subfoveal hyperreflective membrane with overlying trace fluid and mild retinal thickening in the right eye (E) and the left eye (F).</Mark1></Pgraph></Caption>
        </Figure>
        <Figure format="png" height="557" width="695">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
          <Caption><Pgraph><Mark1>Figure 3: Follow-up fundus photo of the right eye (A) and the left eye (B) at six months showing near total resolution of hemorrhage in the right eye and subfoveal scar in both eyes. OCT at final follow-up after six months in the right eye (C) and the left eye (D) reveals an organized subfoveal scar in both eyes without any surrounding edema or fluid.</Mark1></Pgraph></Caption>
        </Figure>
        <NoOfPictures>3</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>